✦ LIBER ✦

Anemia of hematologic malignancies: What are the treatment options?

✍ Scribed by Heinz Ludwig

Book ID: 114106555
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 105 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(02)70174-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erythropoietin for the treatment of anem

Erythropoietin for the treatment of anemia associated with hematological malignancy

✍ T. J. Littlewood 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract Anemia is common in patients with hematological malignancy. Most patients will have their anemia attributed to the anemia of chronic disease. The anemia of chronic disease is caused by cytokine mediated suppression of erythropoiesis and low serum erythropoietin levels are found in the m

The effects of anemia in hematologic mal

The effects of anemia in hematologic malignancies: More than a symptom

✍ Timothy Littlewood; Franco Mandelli 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 71 KB

HLA class II antibodies in the treatment

HLA class II antibodies in the treatment of hematologic malignancies

✍ Michael Dechant; Joerg Bruenke; Thomas Valerius 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

What are the nonsurgical treatment optio

What are the nonsurgical treatment options for obstructive sleep apnea syndrome?

✍ David A Bradshaw 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 90 KB

C.06.02 Early effective treatment in sch

C.06.02 Early effective treatment in schizophrenia – what are the options?

✍ R. Emsley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB

C.01.03 Long-term management of depressi

C.01.03 Long-term management of depression: what are the treatment options?

✍ K. Demyttenaere 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB